Essais liés6clinical trials
VilleChicagolocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05151471

Ouvrir le site du centre

Essais cliniques associés

6
MoléculeIndication / populationPhaseNCTTitreStatut
Prasinezumab Parkinson Phase 2 NCT04777331 PADOVA — A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease ACTIVE_NOT_RECRUITING
Low Dose Benfotiamine Alzheimer Phase 2 NCT06223360 A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam) ACTIVE_NOT_RECRUITING
MT-1186 Sclérose latérale amyotrophique Phase 3 NCT05151471 Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS TERMINATED
Prasinezumab Parkinson Phase 3 NCT07174310 PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease RECRUITING
ALDH2 Genetic Testing in East Asian Community Alzheimer Non applicable NCT07392775 ALDH2 Genetic Testing in East Asian Community NOT_YET_RECRUITING
MT-1186 Sclérose latérale amyotrophique Phase 3 NCT04569084 Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS TERMINATED